当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析

易明医药

(002826)

  

流通市值:19.44亿  总市值:21.05亿
流通股本:1.76亿   总股本:1.91亿

易明医药(002826)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.43亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益73876.13万元,未分配利润33363.97万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产95348.47万元,负债21472.34万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入512,843,177.87351,984,809.03160,425,522.45667,038,998.92
营业总成本488,755,312.52331,773,900.58155,954,093.91647,666,599.63
营业利润51,223,379.8146,402,563.5632,394,318.8823,504,920.63
利润总额50,638,225.1746,231,633.7832,480,811.2723,599,528.66
净利润42,620,637.9139,919,420.3728,050,728.0615,725,638.76
其他综合收益-545,789.14260,935.8845,528.9365,529.06
综合收益总额42,074,848.7740,180,356.2528,096,256.9616,091,167.82
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计524,661,811.1490,015,136.45505,681,820.39489,670,324.23
非流动资产合计428,822,869.44433,731,770.36432,861,030.72438,073,278.62
资产总计953,484,680.54923,746,906.81938,542,851.11927,743,602.85
流动负债合计208,746,547.54181,395,639.53177,737,848.78171,080,065.91
非流动负债合计5,976,867.936,178,233.396,379,598.856,604,315.46
负债合计214,723,415.47187,573,872.92184,117,447.63177,684,381.37
归属于母公司股东权益合计732,918,567.25730,858,322.76749,232,299.07745,017,765.57
股东权益合计738,761,265.07736,173,033.89754,425,403.48750,059,221.48
负债和股东权益合计953,484,680.54923,746,906.81938,542,851.11927,743,602.85
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计611,482,717.11414,135,976.86202,042,040.04940,303,576.42
经营活动现金流出小计497,645,514.58368,004,318.93148,303,516.9773,422,632.47
经营活动产生的现金流量净额113,837,202.5346,131,657.9353,738,523.14166,880,943.95
投资活动现金流入小计201,360,964.85151,145,734.4526,136.17452,321,373.09
投资活动现金流出小计369,430,748.9288,138,592.2154,508,393.6495,322,983.79
投资活动产生的现金流量净额-168,069,784.05-136,992,857.75-154,482,257.43-43,001,610.7
筹资活动现金流入小计7,280,000--11,000,000
筹资活动现金流出小计65,922,826.9155,809,250.3524,601,989.2470,303,212.75
筹资活动产生的现金流量净额-58,642,826.91-55,809,250.35-24,601,989.24-59,303,212.75
汇率变动对现金及现金等价物的影响-88,283.85-7,798.18-29,517.11-3,165.59
现金及现金等价物净增加额-112,963,692.28-146,678,248.35-125,375,240.6464,572,954.91
期末现金及现金等价物余额227,892,039.74194,177,483.67260,480,491.38340,855,732.02
TOP↑